참고문헌
- Yoon HS, Hong SH, Kang HJ, Xu X, Ahn SH. Survival analysis and its prognostic factors after distant relapse in breast cancer patients. J Korean Surg Soc 64: 101-108, 2003
- Song IH. Cancer metastasis and metastasis suppressors. Korea J Gastron 43: 1-7, 2004
- Liotta LA. Cancer cell invasion and metastasis. Sci Am 266: 34-41, 1992
- Chang C, Werb Z. The many faces of metalloproteinases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11(11): S37-S42, 2001
- Hong MK, Cho KY, Oh SJ, Kim KM, Yu SJ. Implication of the activation of matrix metalloproteinase-2 (MMP-2) on the metastasis in breast cancer. J Korean Surg Soc 62(1): 18-25, 2002
- Liu RH. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 78: 517S-520S, 2003
- Waladkhani AR, Clemens MR. Effect of phytochemicals on cancer development. Int J Mol Med 1: 747-753, 1998
- Huang MT, Lou YR, Xie JG, Ma W, Lu YP, Yen P, Zhu BT, Newmark H, Ho CT. Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz [a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. Carcinogenesis 19: 1697-1700, 1998 https://doi.org/10.1093/carcin/19.9.1697
- Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med 9(1): 161-168, 2003 https://doi.org/10.1089/107555303321222856
-
Shah BH, Nawaz Z, Petani SA, Roomi A, Mahmood H, Saeed SA, Gilani AH. Inhibitory effect of curcumin, a food spice from tumeric, on platelet-activating factor and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and
$Ca^{2+}$ signaling. Biochem Pharmacol 58: 1167-1172, 1999 https://doi.org/10.1016/S0006-2952(99)00206-3 - Cheng AL, Hsu CH, Lin KJ, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignat lesions. Anticancer Res 21: 2895-2900, 2001
- Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M, Diederich M. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223: 181-190, 2005 https://doi.org/10.1016/j.canlet.2004.09.041
- Roy M, Chakraborty S, Siddiqi M, Bhattacharya RK. Induction of apoptosis in tumor cells by natural phenolic compounds. Asian Pac J Cancer Prev 3: 61-67, 2002
- Tourkina E, Gooz P, Oates JC, Ludwicka Bradley A, Silver RM, Hoffman S. Curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c anc inhibition of Akt. Carcinogenesis 24: 1199-1208, 2003 https://doi.org/10.1093/carcin/bgg082
- Palmieri D, Lee JW, Juliano RL, Church F. Palsminogen activator inhibitor-1 and -3 increase cell adhesion and motility of MDAMB-435 breast cancer cells. J Bio Chem 277(43): 40950-40957, 2002 https://doi.org/10.1074/jbc.M202333200
- Stracker ML, Engel JD, Wilson LW, Rechler MM, Liotta LA, Schiffmann E. The Type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J Bio Chem 264(36): 21544-21549, 1989
- Plater N, Prevostel C, Deroco D, Joubert D, Rochefort H, Garcia M. Breast cancer invasiveness: Correlation with protein kinase C activity and differential regulation by phobol ester in estrogen receptor -positive and -negative cells. Int J Cancer 75: 750-756, 1998 https://doi.org/10.1002/(SICI)1097-0215(19980302)75:5<750::AID-IJC14>3.0.CO;2-A
-
Huang Q, Shen HM, Ong CN. Inhibitory effect of emodin on tumor invasion through suppression of activator protein 1 and nuclear factor-
${\kappa}$ B. Biochem Pharmal 68: 361-371, 2004 https://doi.org/10.1016/j.bcp.2004.03.032 - Rha SY, Park JO, Gong SJ, Park SH, Yoo NC, Yang WI, Roh JK, Min JS, Lee KS, Kim BS, Chung HC. Clinical relevance of urokinase-type plasminogen activator, uPA receptor, plasminogen activator inhibitor-1 co expression from tissue and serum of breast cancer as targets of biotherapy. J Korean Cancer Assoc 31(2): 56-266, 1999
- Garbisa S, Sartor L, Biggin S, Salvatto B, Benelli R, Albini A. Tumor gelatinases and invasion inhibited by the green tea flavanol epigalloatechin-2-gallate. Cancer 91: 822-832, 2001 https://doi.org/10.1002/1097-0142(20010215)91:4<822::AID-CNCR1070>3.0.CO;2-G
- Johanning GL. Modulation of breast cancer adhesion by unsaturated fatty acids. Nutrition 12: 810-816, 1996 https://doi.org/10.1016/S0899-9007(96)00244-4
- Ohashi Y, Tsuchiya Y, Koizumi K, Sakurai H, Saiki I. Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model. Oncology 65: 250-258, 2003 https://doi.org/10.1159/000074478
- Holy J. Curcumin inhibits cell motility and alters microfilament organization and function in prostate cancer cells. Cell Motil Cytoskeleton 58: 253-268, 2004 https://doi.org/10.1002/cm.20012
-
Lee HY, Bae GU, Jung ID, Lee JS, Kim YH, Noh SH, Stracke ML, Park CG, Lee HW, Han JW. Autotaxin promotes motility via G protein-coupled phosphoinostide 3-kinase
${\gamma}$ in human melanoma cells. FEBS Letters 515: 137-140, 2002 https://doi.org/10.1016/S0014-5793(02)02457-2 - Chen HW, Yu SL, Chen JJ, Li HN, Lin YC, Yao PL, Chou HY, Chien CT, Chen WJ, Lee YT, Yang PC. Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. Mol Pharmacol 65(1): 99-110, 2004 https://doi.org/10.1124/mol.65.1.99
- Kim SY, Jung SH, Lim HS. Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells. Biochem Biophys Res Commun 337(2): 510-516, 2005 https://doi.org/10.1016/j.bbrc.2005.09.079
- Thant AA, Nawa A, Kikkawa F. Ichigotani Y, Ahang Y, Sein TT, Amin AR, Hamaguchi M. Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MARK and the PI3K-Akt pathways in ovarian cancer cells. Cli Exp Metastasis 18(5): 423-428, 2000 https://doi.org/10.1023/A:1010921730952
- Woo MS, Jung SH, Kim SY, Hyun JW, Ko KH, Kim WK, Kim HS. Curcumin suppresses phobal ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in Human astroglioma cells. Biochem Biophys Res Commun 335: 1017-1025, 2005 https://doi.org/10.1016/j.bbrc.2005.07.174
-
Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-
$\kappa$ B signaling. Int J Cancer 111: 679-692, 2004 https://doi.org/10.1002/ijc.20333